July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Characterization of a quantitative model of corneal transplantation in the rabbit
Author Affiliations & Notes
  • David Culp
    Powered Research, LLC, Research Triangle Park, North Carolina, United States
  • Grazia Spiga
    Powered Research, LLC, Research Triangle Park, North Carolina, United States
  • Justin Prater
    Powered Research, LLC, Research Triangle Park, North Carolina, United States
  • Brian C Gilger
    Clinical Sciences, North Carolina State University, Raleigh, North Carolina, United States
  • Footnotes
    Commercial Relationships   David Culp, Powered Research, LLC (E); Grazia Spiga, Powered Research, LLC (E); Justin Prater, Powered Research, LLC (E); Brian Gilger, Powered Research, LLC (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 4370. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      David Culp, Grazia Spiga, Justin Prater, Brian C Gilger; Characterization of a quantitative model of corneal transplantation in the rabbit. Invest. Ophthalmol. Vis. Sci. 2018;59(9):4370.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To develop and characterize a sensitive and translatable model of corneal transplantation in the New Zealand White Rabbit (NZW).

Methods : A 7-mm diameter vacuum trephine was used on the central cornea of NZW recipient eyes, and a 7.5-mm trephine was used to create donor corneas from NZW and Dutch Belted (DB) rabbits. Dexamethasone (DEX) or control were administered topically 3 times a day for 28 days after grafting. Hackett-McDonald (HM) ocular inflammatory scores, rejection index scores, and corneal thickness measurements using spectral domain-optical coherence tomography (SD-OCT, Envisu, Leica) were evaluated on days 1, 3, 5, 7, then weekly through day 28. Corneal endothelial cell (CEC) counts were measured by confocal microscopy (HRT-3, Heidelberg) weekly, and histopathology was done on all grafted eyes at the conclusion of the study.

Results : Cumulative HM scores and rejection index scores were significantly lower (P<0.05) in eyes treated with DEX compared to control on day 3, and remained lower throughout the course of the study. By day 21 more than 50% of control treated eyes had rejected their grafts (rejection index >6), while none of the dex treated eyes rejected by day 28. Corneal thickness measurements, both central and peripheral, were significantly lower (P<0.05) on day 1 in Dex treated eyes, and remained lower than control treated eyes throughout the course of the study. Endothelial cell integrity was significantly better in DEX treated eyes throughout the study, and histologic scores were consistently lower in DEX treated eyes compared to control on day 28.

Conclusions : Using this corneal transplantation model, we demonstrated that topical DEX inhibited ocular inflammation and prolonged rejection compared to control treated eyes. This corneal transplantation model allows quantitative assessment of specific anti-inflammatory and rejection prevention therapies, and can be used in pre-clinical development to provide effective proof of concept of novel compounds or delivery methods.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×